LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

Search

AstraZeneca PLC ADR

Fermé

78.71 0.86

Résumé

Variation du prix de l'action

24h

Actuel

Min

78.57

Max

78.75

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+7.39 upside

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

AstraZeneca PLC ADR Graphique

Actualités Associées

12 juil. 2024, 19:57 UTC

Principaux Mouvements du Marché

Instil Bio Shares Surge Following Rental Agreement with AstraZeneca

15 juil. 2024, 06:04 UTC

Acquisitions, Fusions, Rachats

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15 juil. 2024, 06:04 UTC

Acquisitions, Fusions, Rachats

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15 juil. 2024, 06:02 UTC

Acquisitions, Fusions, Rachats

AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing

15 juil. 2024, 06:02 UTC

Acquisitions, Fusions, Rachats

AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B

15 juil. 2024, 06:01 UTC

Acquisitions, Fusions, Rachats

AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage Pipeline

15 juil. 2024, 06:00 UTC

Acquisitions, Fusions, Rachats

AstraZeneca Completes Acquisition of Amolyt Pharma

15 juil. 2024, 06:00 UTC

Acquisitions, Fusions, Rachats

AstraZeneca PLC Acquisition of Amolyt Pharma completed

15 juil. 2024, 06:00 UTC

Acquisitions, Fusions, Rachats

AstraZeneca PLC Acquisition of Amolyt Pharma completed

20 juin 2024, 20:16 UTC

Actualités

Why Wall Street Is Chasing Ozempic Wannabes -- Heard on the Street -- Update

20 juin 2024, 18:09 UTC

Actualités

Why Wall Street Is Chasing Ozempic Wannabes -- Heard on the Street -- Update

20 juin 2024, 11:00 UTC

Actualités

Why Wall Street Is Chasing Ozempic Wannabes -- Heard on the Street -- WSJ

10 juin 2024, 06:14 UTC

Market Talk

AstraZeneca Looks Well on Track to Reach 2030 Revenue Target -- Market Talk

7 juin 2024, 11:55 UTC

Actualités

Germany's Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions - Interview

5 juin 2024, 06:00 UTC

Acquisitions, Fusions, Rachats

AstraZeneca PLC Acquisition of Fusion completed

5 juin 2024, 06:00 UTC

Acquisitions, Fusions, Rachats

AstraZeneca PLC Acquisition of Fusion completed

5 juin 2024, 04:45 UTC

Acquisitions, Fusions, Rachats

AstraZeneca Announced Acquisition on March 19

5 juin 2024, 04:43 UTC

Acquisitions, Fusions, Rachats

AstraZeneca Completes Acquisition of Fusion Pharmaceuticals

31 mai 2024, 20:08 UTC

Acquisitions, Fusions, Rachats

Fusion Pharmaceuticals Shareholders to Get Deferred Payment in Form of Contingent Value Right of $3/Shr if Milestone Is Achieved >FUSN

31 mai 2024, 20:07 UTC

Acquisitions, Fusions, Rachats

Fusion Pharmaceuticals Shareholders to Receive $21/Shr in Cash Upfront on Completion of Deal >FUSN

31 mai 2024, 20:06 UTC

Acquisitions, Fusions, Rachats

Fusion Pharmaceuticals Receives Final Court Order Approving AstraZeneca Deal >FUSN

31 mai 2024, 13:24 UTC

Actualités
Acquisitions, Fusions, Rachats

AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030 -- Interview

31 mai 2024, 13:23 UTC

Acquisitions, Fusions, Rachats

AstraZeneca CEO: Company Doesn't Need Further Mergers and Acquisitions

31 mai 2024, 13:23 UTC

Acquisitions, Fusions, Rachats

AstraZeneca CEO: U.S. Inflation Reduction Act Could Hit Top Line By Around $500M

31 mai 2024, 13:23 UTC

Acquisitions, Fusions, Rachats

AstraZeneca's CEO Pascal Soriot Says He Has No Plans to Retire

21 mai 2024, 07:30 UTC

Market Talk

AstraZeneca's Revenue Target Signals Pipeline Momentum -- Market Talk

21 mai 2024, 06:17 UTC

Actualités

AstraZeneca Targets $80B Revenue by 2030 Through Pipeline Expansion

25 avr. 2024, 16:43 UTC

Résultats

AstraZeneca, Anglo American, Deutsche Bank: European Stocks in Focus -- WSJ

25 avr. 2024, 15:28 UTC

Résultats

AstraZeneca, Anglo American, Deutsche Bank: European Stocks in Limelight -- WSJ

25 avr. 2024, 11:31 UTC

Résultats

AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags -- IBD

Comparaison

Variation de prix

AstraZeneca PLC ADR prévision

Objectif de Prix

By TipRanks

7.39% hausse

Prévisions sur 12 Mois

Moyen 83.83 USD  7.39%

Haut 97 USD

Bas 74 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

8 ratings

7

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

77.86 / 79.79Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Neutral Evidence

Long Terme

Weak Bullish Evidence